4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Artiva Biotherapeutics, Inc. (ARTV) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 106 employees. Its market capitalization is roughly $487 million. In the fiscal year ended 2025-12-31, ARTV reported $0M in revenue and ($84M) in net income.
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $34M | $5M | — |
| Operating Income (EBIT) | ($90M) | ($67M) | ($31M) | ($60M) | — |
| Net Income | ($84M) | ($58M) | ($33M) | ($61M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($24M) | ($22M) | ($23M) | ($23M) | ($22M) | — |
| Net Income | ($24M) | ($21M) | ($22M) | ($21M) | ($20M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $131M | $210M | $105M | $133M | — |
| Total Liabilities | $21M | $23M | $267M | $274M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ARTV viewer.
About TickerBase · Data methodology & sources